Cargando…
In vivo Susceptibility of Plasmodium vivax to Chloroquine in Southeastern Iran
BACKGROUND: Plasmodium vivax is the predominant species causes of malaria with about 90% total annual reported malaria in Iran. This study conducted to determine the susceptibility of Plasmodium vivax isolates to chloroquine in Sistan and Balochistan Province, southeastern Iran. METHODS: A total 270...
Autores principales: | Heidari, A, Keshavarz, H, Shojaee, S, Raeisi, A, Dittrich, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469182/ https://www.ncbi.nlm.nih.gov/pubmed/23109940 |
Ejemplares similares
-
Therapeutic efficacy of chloroquine and primaquine for Plasmodium vivax malaria treatment in southeast Iran
por: Heidari, Aliehsan, et al.
Publicado: (2012) -
Molecular Monitoring of Plasmodium vivax Infection after Radical Treatment in Southeastern Iran
por: Nateghpour, M, et al.
Publicado: (2010) -
Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Antimalarials in Southeastern Iran
por: AZARIAN MOGHADAM, Hamid, et al.
Publicado: (2018) -
Genetic Variation of MSP-1 Gene in Plasmodium vivax Isolated from Patients in Hormozgan Province, Iran using SSCP-PCR
por: Miahipour, A, et al.
Publicado: (2012) -
Molecular epidemiology of potential candidate markers for chloroquine resistance in imported Plasmodium vivax malaria cases in Iran
por: Pirahmadi, Sakineh, et al.
Publicado: (2023)